About Integrity Implants
Integrity Implants is a private company based in Palm Beach Gardens, Florida. It has reported $13,638,635 raised in four offerings on Form D since April 2016. Its chief executive is Kevin McGann.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 23, 2025 | Jun 6, 2025 | $6,075,203of $7.5M target | 3 | $2.0M | EquityRule 506(b) | Form D ↗ |
| Jul 26, 2021 | Sep 24, 2021 | $2,688,550of $39.0M target | 10 | $268K | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Feb 1, 2020 | Feb 27, 2020 | $804,882of $9.9M target | 13 | $61,914 | EquityRule 506(b) | Form D ↗ |
| Apr 21, 2016 | Apr 29, 2016 | $4,070,000of $12.5M target | 10 | $407K | EquityRule 506(c) | Form D ↗ |
| Total, four offerings | $13,638,635 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Integrity Implants's Form D filed Jun 6, 2025.
Earlier filings also listed Wyatt Geist (executive officer and director, last listed Sep 2021), Richard Stone (executive officer, last listed Sep 2021), Paul Birkmeyer (director, last listed Sep 2021), Nathan Ward (director, last listed Sep 2021), Kevin Williamson (executive officer, last listed Sep 2021), John Clayton (executive officer and director, last listed Sep 2021), Edward Lipes (director, last listed Sep 2021) and Christopher Walsh (chief executive officer and director, last listed Sep 2021).